| Literature DB >> 15886703 |
A S Adelman1, C C McLaughlin, X-C Wu, V W Chen, F D Groves.
Abstract
Acute lymphocytic leukaemia (ALL) incidence among children under 5 years of age was examined, utilising data from 24 United States cancer registries. County-based incidence rates among white children were compared across four levels of urbanisation: large and small metropolitan counties, and adjacent and nonadjacent rural counties. In metropolitan areas, the incidence of ALL was lower among blacks (rate ratio (RR)=0.38, confidence interval (CI)=0.33-0.44) and among Asians/Pacific Islanders (RR=0.78, CI=0.63-0.97) than among whites. Among white children, the incidence of ALL decreased across the four strata of urbanisation, from 67 to 62 to 65 to 54 cases per million person-years at-risk (two-sided trend P=0.009), such that rates were significantly lower in the most remote rural counties than in the most populous metropolitan counties (RR=0.80, 95% CI=0.70-0.91).Entities:
Mesh:
Year: 2005 PMID: 15886703 PMCID: PMC2361799 DOI: 10.1038/sj.bjc.6602607
Source DB: PubMed Journal: Br J Cancer ISSN: 0007-0920 Impact factor: 7.640
Classification of counties by degree of urbanisation
|
|
|
|
|---|---|---|
| Urban | 1. Counties in metropolitan areas with population ⩾1 000 000 | 0: ‘Central counties’ |
| 1: Fringe counties | ||
| 2. Counties in metropolitan areas with population <1 000 000 | 2: Population 250 000–1 000 000 | |
| 3: Population <250 000 | ||
| Rural | 3. Counties adjacent to metropolitan area | 4: Urban population ⩾20 000 |
| 6: Urban population 2500–19 999 | ||
| 8: Completely rural or urban population <2500 | ||
| 4. Counties not adjacent to metropolitan area | 5: Urban population ⩾20 000 | |
| 7: Urban population 2500–19 999 | ||
| 9: Completely rural or urban population <2500 | ||
Beale C (2003). Description of the rural–urban continuum codes prior to 2003. USDA Economic Research Service: http://www.ers.usda.gov/Briefing/Rurality/RuralurbCon/priordescription.htm.
Racial characteristics of cases
|
|
|
|
|
| |
|---|---|---|---|---|---|
| ALL, all counties (2423 cases) | 89 | 7 | 3 | 1 | 1 |
| ALL, metro (1921 cases) | 88 | 8 | 3 | 1 | 1 |
| ALL, nonmetro (502 cases) | 92 | 4 | 2 | 1 | 1 |
| ANLL, all counties (429 cases) | 81 | 13 | 5 | 0 | 0 |
| NHL, all counties (144 cases) | 84 | 10 | 6 | 0 | 0 |
Note: Percentages are given due to privacy concerns associated with small, exact numbers in some categories. For purposes of this study, ALL (acute lymphocytic leukaemia) is defined as International Classification of Diseases for Oncology, 2nd edn (ICD-O-2) morphology codes 9821 and 9828; ANLL (acute nonlymphocytic leukaemia) is defined as codes 9840, 9841, 9861, 9864, 9866, 9867, 9871–9874, 9891, 9894, and 9910; and NHL (non-Hodgkin's lymphoma) is defined as codes 9590, 9591–9595, 9670–9688, 9690–9717, 9720, 9723, and 9731–9764.
API=Asian/Pacific Islander, AIAN=American Indian/Alaska Native.
Paediatric (ages 0–4) cancer incidence rates (per 1 000 000) for both genders combined by race and RRs contrasting incidence rates by race in metropolitan counties of 23 US states and Atlanta, 1995–2000
|
|
|
| ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
|
| Black | 5 985 970 | 149 | 25 (21–29) | 0.38 (0.33–0.44) | 47 | 8 (6–10) | 0.74 (0.57–0.95) | 25 | 4 (3–6) | 0.56 (0.40–0.80) |
| API | 1 167 614 | 59 | 50 (38–65) | 0.78 (0.63–0.97) | <20 |
|
| <20 |
|
|
| White | 25 941 007 | 1685 | 65 (62–68) | 1.00 (Referent) | 277 | 11 (10–12) | 1.00 (Referent) | 192 | 7 (6–8) | 1.00 (Referent) |
Source: North American Association of Central Cancer Registries.
Not shown due to sparse data (N<20).
RR=rate ratio, ALL=acute lymphocytic leukaemia, ANLL=acute nonlymphocytic leukaemia, NHL=non-Hodgkin's lymphoma, API=Asian/Pacific Islander, AIAN=American Indian/Alaska Native.
Paediatric (ages 0–4) cancer incidence rates (per 1 000 000) for both genders combined by degree of urbanisation and gender and RRs contrasting incidence rates by degree of urbanisation in 23 US states and Atlanta among whites, 1995–2000
|
|
|
| ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
|
| Metro⩾1M | 14 853 994 | 997 | 67 (63–71) | 1.00 (Referent) | 157 | 11 (9–12) | 1.00 (Referent) | 115 | 8 (6–9) | 1.00 (Referent) |
| Metro<1M | 11 087 013 | 688 | 62 (58–67) | 0.92 (0.85–1.00) | 120 | 11 (9–13) | 1.02 (0.84–1.25) | 77 | 7 (6–9) | 0.90 (0.70–1.14) |
| Nonmetro adj. | 4 064 046 | 263 | 65 (57–73) | 0.96 (0.86–1.08) | 40 | 10 (7–13) | 0.93 (0.70–1.25) | 23 | 6 (4–8) | 0.73 (0.50–1.06) |
| Nonmetro non-adj. | 3 702 524 | 199 | 54 (46–62) | 0.80 (0.70–0.91) | 32 | 9 (6–12) | 0.82 (0.59–1.12) | <20 |
|
|
| Two-sided trend | ||||||||||
Source: North American Association of Central Cancer Registries.
RR=rate ratio, ALL=acute lymphocytic leukaemia, ANLL=acute nonlymphocytic leukaemia, NHL=non-Hodgkin's lymphoma.
Not shown due to sparse data (N<20).